KaloBios Gets Final Nod On 'Unusual' $3M Ch. 11 Package

Bankrupt drug developer KaloBios Pharmaceuticals received final approval Thursday for a $3 million debtor-in-possession package that will convert to equity for lenders Black Horse Capital and Nomis Bay once the company...

Already a subscriber? Click here to view full article